Welcome and Introductions

Doug Mowen
Managing Director, Medical Device Industry Lead, PricewaterhouseCoopers, Florham Park, NJ (Co chair)

Overview of Implementation of the AdvaMed Code of Ethics

Link Bonforte
President, LB1 Consulting LLC; Former Vice President, Ethics & Compliance, ConvaTec Inc., Belle Mead, NJ (Co chair)

Kristine A. Rapp, Esq.
Vice President, Global Ethics and Compliance, Hospira, Inc., Lake Forest, IL (Co chair)

John Bentivoglio, Esq.
Partner, Skadden Arps LLP; Former Special Counsel for Health Care Fraud and Chief Privacy Officer, United States Department of Justice, Washington, DC (Moderator)
Presentation Material (Acrobat)

After the Implementation: Maintaining an Effective Compliance Program

Amy B. Manning
Partner and Co-Chair of the McGuireWoods LLP Life Science Industry Group, McGuireWoods LLP, Chicago, IL
Presentation Material (Acrobat)

Jean Sands
Manager, Pharmaceuticals and LifeSciences, PricewaterhouseCoopers, Chicago, IL
Presentation Material (Acrobat)

AdvaMed Code of Ethics Certification: A Primer for Certifying Compliance with the Code

Paul J. Silver
Managing Director and Practice Leader, Life Sciences Advisory Services, Huron Consulting Group, Atlanta, GA

Rosemary Weghorst, MHA
Manager, Life Sciences Advisory Services, Huron Consulting Group, Chicago, IL
Presentation Material (Acrobat)

Break

Federal Panel: Key Congressional Transparency Initiatives

Emilia DiSanto
Chief Investigative Counsel and Special Counsel for Senator Grassley (R-IA), Washington, DC

Jack Mitchell
Chief of Oversight and Investigations, Special Committee on Aging, United States Senate; Former Director, Commissioner's Office of Special Investigations (OSI), FDA, Washington, DC

Daniel F Donovan, III, Esq.
Partner, King & Spalding; Former Senior Investigative Counsel to Senator Charles E. Grassley (R-IA), Washington, DC (Moderator)

State Panel: State Disclosure Initiatives

Allan Coukell
Director, Pew Prescription Project, The Pew Charitable Trusts, Pew Health Group, Boston, MA

Melissa J. Lopes, Esq.
Deputy General Counsel, Massachusetts Department of Public Health, Boston, MA

Benjamin S. Martin, Esq.
Associate, Health Care and Life Sciences Practice, Epstein Becker & Green, Washington, DC (Co moderator)

Jeffrey L. Handwerker, Esq.
Partner, Arnold & Porter, Washington, DC (Co moderator)

Panel: Operational Implications of State and Possible Federal Disclosure Requirements

Jacqueline K. Huber
Corporate Vice President and Chief Compliance Officer, Biomet, Inc., Warsaw, IN

Eric M. Baim, Esq.
Associate, Hogan & Hartson, Washington, DC

Adjournment and Opening Networking Reception